Northwest Biotherapeutics Inc. completed the acquisition of Advent BioServices Ltd. on October 24, 2025, receiving significant assets including cryostorage equipment; the deal involves payments of £1.4 million and accounts payable already due, with 19 million NWBio securities reverting to the company.